Craig Hettenbach
Stock Analyst at Morgan Stanley
(2.71)
# 1,724
Out of 5,182 analysts
310
Total ratings
59.03%
Success rate
-0.87%
Average return
Main Sectors:
Stocks Rated by Craig Hettenbach
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAY Waystar Holding | Initiates: Equal-Weight | $28 | $25.27 | +10.80% | 1 | Mar 30, 2026 | |
| OMDA Omada Health | Maintains: Overweight | $32 → $30 | $14.15 | +112.01% | 2 | Mar 6, 2026 | |
| VEEV Veeva Systems | Maintains: Equal-Weight | $205 → $215 | $158.22 | +35.89% | 11 | Mar 5, 2026 | |
| HIMS Hims & Hers Health | Maintains: Equal-Weight | $40 → $21 | $26.33 | -20.24% | 5 | Feb 25, 2026 | |
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $5 → $4 | $2.29 | +74.67% | 3 | Dec 18, 2025 | |
| AMWL American Well | Maintains: Equal-Weight | $11 → $6 | $6.12 | -1.96% | 6 | Dec 18, 2025 | |
| HCA HCA Healthcare | Downgrades: Underweight | $425 | $434.78 | -2.25% | 5 | Dec 15, 2025 | |
| ARDT Ardent Health | Downgrades: Equal-Weight | $22 → $12 | $9.63 | +24.61% | 3 | Nov 14, 2025 | |
| HNGE Hinge Health | Maintains: Overweight | $57 → $67 | $43.99 | +52.31% | 3 | Sep 23, 2025 | |
| SLAB Silicon Laboratories | Maintains: Equal-Weight | $157 → $144 | $217.19 | -33.70% | 15 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $175 → $210 | $180.10 | +16.60% | 3 | Jun 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $200 | $167.97 | +19.07% | 1 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $9 → $5 | $0.93 | +435.05% | 12 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $96 → $114 | $62.66 | +81.93% | 24 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $62 → $57 | $39.57 | +44.05% | 19 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $81 | $90.17 | -10.17% | 23 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $35 | $24.20 | +44.63% | 4 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $17.93 | +0.39% | 4 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $208 → $185 | $86.48 | +113.92% | 23 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $162 → $167 | $205.25 | -18.64% | 23 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $42 → $42 | $148.38 | -71.69% | 25 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $159 | $189.32 | -16.02% | 2 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $125 | $83.90 | +48.99% | 3 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $72 | $405.45 | -82.17% | 22 | Dec 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $193 → $195 | $269.22 | -27.57% | 3 | Oct 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $488 | $370.74 | +31.63% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $297 → $296 | $196.49 | +50.64% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $273 → $368 | $257.14 | +43.11% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $513 | $243.12 | +111.01% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $321 → $275 | $292.32 | -5.93% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $88 | $53.98 | +63.02% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | n/a | $98.86 | - | 11 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $173 → $185 | $88.54 | +108.95% | 2 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $190 → $213 | $289.25 | -26.36% | 19 | Apr 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $53 → $58 | $120.04 | -51.68% | 12 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $101 → $117 | $389.31 | -69.95% | 15 | Jun 16, 2020 |
Waystar Holding
Mar 30, 2026
Initiates: Equal-Weight
Price Target: $28
Current: $25.27
Upside: +10.80%
Omada Health
Mar 6, 2026
Maintains: Overweight
Price Target: $32 → $30
Current: $14.15
Upside: +112.01%
Veeva Systems
Mar 5, 2026
Maintains: Equal-Weight
Price Target: $205 → $215
Current: $158.22
Upside: +35.89%
Hims & Hers Health
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $40 → $21
Current: $26.33
Upside: -20.24%
GoodRx Holdings
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $5 → $4
Current: $2.29
Upside: +74.67%
American Well
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $11 → $6
Current: $6.12
Upside: -1.96%
HCA Healthcare
Dec 15, 2025
Downgrades: Underweight
Price Target: $425
Current: $434.78
Upside: -2.25%
Ardent Health
Nov 14, 2025
Downgrades: Equal-Weight
Price Target: $22 → $12
Current: $9.63
Upside: +24.61%
Hinge Health
Sep 23, 2025
Maintains: Overweight
Price Target: $57 → $67
Current: $43.99
Upside: +52.31%
Silicon Laboratories
Aug 6, 2025
Maintains: Equal-Weight
Price Target: $157 → $144
Current: $217.19
Upside: -33.70%
Jun 9, 2025
Maintains: Overweight
Price Target: $175 → $210
Current: $180.10
Upside: +16.60%
Mar 26, 2025
Initiates: Equal-Weight
Price Target: $200
Current: $167.97
Upside: +19.07%
Aug 6, 2024
Maintains: Equal-Weight
Price Target: $9 → $5
Current: $0.93
Upside: +435.05%
Feb 7, 2023
Maintains: Equal-Weight
Price Target: $96 → $114
Current: $62.66
Upside: +81.93%
Jun 10, 2022
Maintains: Overweight
Price Target: $62 → $57
Current: $39.57
Upside: +44.05%
Jun 10, 2022
Maintains: Overweight
Price Target: $85 → $81
Current: $90.17
Upside: -10.17%
May 18, 2022
Maintains: Equal-Weight
Price Target: $55 → $35
Current: $24.20
Upside: +44.63%
Mar 28, 2022
Maintains: Overweight
Price Target: $20 → $18
Current: $17.93
Upside: +0.39%
Feb 3, 2022
Maintains: Overweight
Price Target: $208 → $185
Current: $86.48
Upside: +113.92%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $162 → $167
Current: $205.25
Upside: -18.64%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $42 → $42
Current: $148.38
Upside: -71.69%
Dec 17, 2021
Maintains: Equal-Weight
Price Target: $165 → $159
Current: $189.32
Upside: -16.02%
Dec 13, 2021
Maintains: Overweight
Price Target: $115 → $125
Current: $83.90
Upside: +48.99%
Dec 10, 2021
Maintains: Overweight
Price Target: $57 → $72
Current: $405.45
Upside: -82.17%
Oct 27, 2021
Maintains: Underweight
Price Target: $193 → $195
Current: $269.22
Upside: -27.57%
Aug 31, 2021
Maintains: Overweight
Price Target: $515 → $488
Current: $370.74
Upside: +31.63%
Aug 31, 2021
Maintains: Overweight
Price Target: $297 → $296
Current: $196.49
Upside: +50.64%
Aug 31, 2021
Maintains: Overweight
Price Target: $273 → $368
Current: $257.14
Upside: +43.11%
Aug 31, 2021
Maintains: Overweight
Price Target: $500 → $513
Current: $243.12
Upside: +111.01%
Aug 31, 2021
Maintains: Overweight
Price Target: $321 → $275
Current: $292.32
Upside: -5.93%
Aug 31, 2021
Maintains: Overweight
Price Target: $94 → $88
Current: $53.98
Upside: +63.02%
Aug 3, 2021
Upgrades: Equal-Weight
Price Target: n/a
Current: $98.86
Upside: -
May 7, 2021
Maintains: Overweight
Price Target: $173 → $185
Current: $88.54
Upside: +108.95%
Apr 8, 2021
Downgrades: Equal-Weight
Price Target: $190 → $213
Current: $289.25
Upside: -26.36%
Feb 11, 2021
Maintains: Equal-Weight
Price Target: $53 → $58
Current: $120.04
Upside: -51.68%
Jun 16, 2020
Maintains: Equal-Weight
Price Target: $101 → $117
Current: $389.31
Upside: -69.95%